Hepatitis B virus immunopathology

This publication has 64 references indexed in Scilit:

• Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans.
  Journal of Clinical Investigation, 1995
• Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis.
  The Journal of Experimental Medicine, 1993
• Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1
  Nature, 1993
• The Complete Nucleotide Sequence of a Pre-core Mutant of Hepatitis B Virus Implicated in Fulminant Hepatitis and Its Biological Characterization in Chimpanzees
  Virology, 1993
• Cell Biology of Antigen Processing and Presentation to Major Histocompatibility Complex Class I Molecule-Restricted T Lymphocytes
  Published by Elsevier ,1992
• Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen.
  The Journal of Experimental Medicine, 1991
• Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA.
  Proceedings of the National Academy of Sciences, 1991
• Extrathymic tolerance of mature T cells: Clonal elimination as a consequence of immunity
  Cell, 1990
• T cells can present antigens such as HIV gp120 targeted to their own surface molecules
  Nature, 1988
• Functional characterization of cloned intrahepatic, hepatitis B virus nucleoprotein-specific helper T cell lines.
  The Journal of Immunology, 1987